Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/541
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
Indium In-111 Chloride (Solution)
|
| dailymed-instance:descripti... |
Indium In 111 Chloride Sterile Solution is indicated for radiolabeling OncoScint CR/OV and ProstaScint preparations used for in vivo diagnostic imaging procedures. It is also indicated for radiolabeling Zevalinpreparations used for Radioimmunotherapy procedures. It is supplied as a sterile, non-pyrogenic solution of Indium In 111 Chloride in 0.05 molar hydrochloric acid. No carrier has been added to the solution. Each 0.5 milliliter of the solution contains 185 megabequerels (5 millicuries) of indium In 111 chloride at time of calibration (specific activity of>1.85 GBq/��g Indium;>50 mCi/��g Indium at this time of calibration). The solution pH is 1.1 to 1.4.
|
| dailymed-instance:clinicalP... |
Please refer to the package insert for OncoScint CR/OV, ProstaScint or Zevalin for this information on the final drug product.
|
| dailymed-instance:activeIng... | |
| dailymed-instance:contraind... |
Please refer to the package insert for OncoScint CR/OV, ProstaScint, or Zevalin for this information on the final drug product.
|
| dailymed-instance:supply |
Indium In 111 Chloride Sterile Solution is supplied in 10 mL vials containing 0.5 mL of solution. It is a sterile non-pyrogenic solution in 0.05 molar hydrochloric acid. No carrier is added to the solution. Each 0.5 mL contains 185 megabequerels (5 millicuries) of Indium In 111 Chloride at time of calibration. The pH of the solution is 1.1 to 1.4.
|
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... | |
| dailymed-instance:precautio... |
General: Caution must be used to maintain proper aseptic technique while withdrawing and transferring contents of the Indium Chloride solution vial. Do not use after expiration time and date indicated on vial label. Contents of the vial are radioactive and adequate shielding and handling precautions must be maintained at all times.<br/>Carcinogenesis, Mutagenesis and Impaired Fertility: Please refer to the package insert for OncoScint CR/OV, ProstaScint, or Zevalin for this information on the final drug product.<br/>Pregnancy Category: Please refer to the package insert for OncoScint CR/OV, ProstaScint, or Zevalin for this information on the final drug product.<br/>Nursing Mothers: Please refer to the package insert for OncoScint CR/OV, ProstaScint, or Zevalin for this information on the final drug product.<br/>Pediatric Use: Please refer to the package insert for OncoScint CR/OV, ProstaScint, or Zevalin for this information on the final drug product.
|
| dailymed-instance:genericMe... |
Indium In-111 Chloride
|
| dailymed-instance:fullName |
Indium In-111 Chloride (Solution)
|
| dailymed-instance:adverseRe... |
Please refer to the package insert for OncoScint CR/OV, ProstaScint, or Zevalin for this information on the final drug product.
|
| dailymed-instance:warning |
CONTENTS OF THE VIAL OF INDIUM In 111 CHLORIDE SOLUTION ARE INTENDED ONLY TO BE USED AS AN INGREDIENT FOR RADIOLABELING ONCOSCINT CR/OV OR PROSTASCINT FOR USE IN IN VIVO DIAGNOSTIC IMAGING PROCEDURES OR TO BE USED AS AN INGREDIENT FOR RADIOLABELING ZEVALIN���FOR USE IN RADIOIMMUNOTHERAPY PROCEDURES, AND ARE NOT TO BE ADMINISTERED DIRECTLY TO HUMANS.
|
| dailymed-instance:indicatio... |
Indium In 111 Chloride Sterile Solution is indicated for radiolabeling OncoScint CR/OV or ProstaScmt preparations used for in vivo diagnostic imaging procedures. It is also indicated for radiolabeling Zevalin preparations used for Radioimmunotherapy procedures. Please refer to the package insert for OncoScint CR/OV, ProstaScint or Zevalin for information on the final drug product.
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
Indium In-111 Chloride
|